Search results
1 lip 2009 · A generic version of Multaq has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Multaq and have been approved by the FDA: dronedarone hydrochloride tablet;oral. Manufacturer: LUPIN.
Find detailed information about Multaq, an anti-heart failure drug by Sanofi Aventis Us. Learn about its uses, patents, and potential release date for generic versions. Check out the patent details and stay updated on generic releases after June 30, 2031.
21 lis 2023 · Multaq is only available as a brand-name drug. It doesn’t come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication.
Dronedarone, sold under the brand name Multaq, is a class III antiarrhythmic medication developed by Sanofi-Aventis. [citation needed] It was approved by the US Food and Drug Administration (FDA) in July 2009.
9 sie 2011 · That article examined Multaq’s pros and cons by sifting through reports of problems and possible hazards that have been linked to the drug. Our goal was to help people with afib make their own judgment about Multaq.
24 kwi 2024 · Common Brand Name(s): Multaq; Common Generic Name(s): dronedarone; dronedarone HCl; dronedarone hydrochloride; Pronunciation: MUL-tak; Drug Classes: antiarrhythmic agent
Overview. This is a summary of the European public assessment report (EPAR) for Multaq. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Multaq.
